StockData
Pulmonx Corp logo

Pulmonx Corp (LUNG) income statement

LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.69−0.04 (-1.65%)

Close on Nov 18, 2026Market cap $115.53MP/E –Yield –

Pulmonx Corp income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
77.1%
Operating margin
-53.0%
Net margin
-55.0%
Return on equity, FY2025
-77.2%

Financial strength

Current ratio
4.32
Debt to equity
0.96
Debt to assets
32.7%
Cash to current liabilities
273.7%

Valuation

P/E ratio
–
Price to sales
1.32
Price to book
2.95
Dividend yield
–

See a number that looks wrong?